Search research articles
Contact Us
Filters
Showing results (411-420 of 652) with videos related to
Page
of 66
Sort By:
International Journal of Molecular Sciences
|
April 28, 2023
Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis
Jaclyn C Strauss, Natasha Haskey, Hena R Ramay, et al.
Crohn'S & Colitis 360
|
May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey
Remo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies
Bruce E Sands, Geert D'Haens, Remo Panaccione, et al.
The American Journal of Gastroenterology
|
August 27, 2014
Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3
Jean-Frederic Colombel, William J Sandborn, Subrata Ghosh, et al.
Journal of Crohn'S & Colitis
|
April 1, 2025
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Walter Reinisch, Edward V Loftus, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
Stephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Crohn'S & Colitis 360
|
March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
Remo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology
|
February 7, 2025
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study
Jurij Hanžel, Gregor Novak, Vipul Jairath, et al.
Digestive Diseases and Sciences
|
May 3, 2024
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study
Stefan Schreiber, Theresa Hunter Gibble, Remo Panaccione, et al.
Advances in Therapy
|
August 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Gerd R Burmester, Atul Deodhar, Alan D Irvine, et al.
Page
of 66
Search research articles
Search
Showing results (411-420 of 652) with videos related to
Sort By:
Page
of 66
International Journal of Molecular Sciences
|
April 28, 2023
Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis
Jaclyn C Strauss, Natasha Haskey, Hena R Ramay, et al.
Crohn'S & Colitis 360
|
May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey
Remo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies
Bruce E Sands, Geert D'Haens, Remo Panaccione, et al.
The American Journal of Gastroenterology
|
August 27, 2014
Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3
Jean-Frederic Colombel, William J Sandborn, Subrata Ghosh, et al.
Journal of Crohn'S & Colitis
|
April 1, 2025
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Walter Reinisch, Edward V Loftus, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
Stephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Crohn'S & Colitis 360
|
March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
Remo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology
|
February 7, 2025
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study
Jurij Hanžel, Gregor Novak, Vipul Jairath, et al.
Digestive Diseases and Sciences
|
May 3, 2024
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study
Stefan Schreiber, Theresa Hunter Gibble, Remo Panaccione, et al.
Advances in Therapy
|
August 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Gerd R Burmester, Atul Deodhar, Alan D Irvine, et al.
Page
of 66